DrugRisk Reports Stryker Hip Recall Lawsuit Could Move to Federal MDL Court

The Drug Risk Resource Center is the Web’s largest source for information on medical device warnings, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
DrugRisk Dangerous Drugs
Anyone who is subject to the Stryker Rejuvenate or ABG II hip recall is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Orlando, FL (PRWEB) March 15, 2013

The hip implant safety advocates at DrugRisk.com are alerting patients affected by the Stryker Rejuvenate or ABG II hip recall of legal news updates to the site showing plaintiffs have requested that lawsuits be moved to a special federal multi-district court.

“The goal of DrugRisk is to improve consumer safety by sharing the latest medical device warnings, recalls, studies and litigation news. Informed patients can discuss recall options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center contains warnings from health experts with the British Medical Journal* and FDA**, as well as others, that the toxic metal shavings from Metal-on-metal hips like Stryker can have dangerous effects on tissue, bone and other organs when released into the body.

DrugRisk has also added the recent Stryker hip recall of the Rejuvenate and ABG II modular implant systems.*** Information provided in the recall indicates some patients have experienced adverse local tissue reactions or elevated levels of metal in the bloodstream, even if no symptoms are present.***

Now, the resource center has learned that patients have filed a petition on February 19th with the U.S. Judicial Panel on Multidistrict Litigation, asking that Stryker hip recall lawsuits be consolidated to a special federal multi-district litigation court in the U.S. District Court, District of Minnesota. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))

As part of the recall, Stryker hired the claims management company Broadspire to attempt to resolve claims for certain costs.*** However, the resource center cautions that patients should speak with a lawyer about their full legal rights before signing anything from Stryker or Broadspire, or deciding to take action.

Anyone who is subject to the Stryker Rejuvenate or ABG II hip recall is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL medical injury cases, DrugRisk only recommends lawyers and law firms who have already handled Stryker recall lawsuits.

For more information on the recall, studies and litigation news related to Stryker or other metal hips, or to speak with a lawyer, visit http://www.DrugRisk.com.

*bmj.com/content/344/bmj.e1410
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
***stryker.com/en-us/products/Orthopaedics/modularneckstems/index.htm


Contact